Retinal Degeneration Fund
Funding rounds backed by Retinal Degeneration Fund.
- Funding disclosed in full
- $190M
- Median round
- $190M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Osanni Bio Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model | $190MSeries B | BiotechUnited States |